|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0600 AUD | -1.64% |
|
-3.23% | -29.41% |
EPS & Dividend: Neurizon Therapeutics Limited
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0046 | -0.004235 | -0.00539 | -0.0194 | -0.0207 | -0.034 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 0.1550 | 0.0910 | 0.0700 | 0.0750 | 0.1950 | 0.1600 |
| Nbr of stocks (in thousands) | 3,02,021 | 3,16,730 | 3,16,912 | 3,47,475 | 4,45,024 | 4,92,306 |
| Announcement Date | 18/09/20 | 18/08/21 | 26/08/22 | 31/08/23 | 30/08/24 | 25/08/25 |
1AUD in Million2AUD
Estimates
Past dividends: Neurizon Therapeutics Limited
| 29/12/2025 | Ex-dividend date - 0.98319 AUD | 10:30 am |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 0.6% | 0.67% | 33.11x | 19.76x | 12.04x | |
| 2.29% | 2.39% | 24.88x | 6.26x | 5.74x | |
| 3.02% | 3.18% | 27.82x | -827.16x | 6.77x | |
| 3.07% | 3.14% | 17.55x | 6.47x | 4.34x | |
| 1.8% | 1.9% | 23.42x | 5.41x | 4.85x | |
| 3.06% | 3.14% | 20.62x | 6.16x | 5.32x | |
| 4% | 3.84% | 12.56x | 5.5x | 4.71x | |
| 2.89% | 3.05% | 22.73x | 16.95x | 6.08x | |
| 2.51% | 2.57% | -46.22x | 8.77x | 5.58x | |
| Average | 2.58% | 2.65% | 15.16x | -83.54x | 6.16x | |
| Weighted average by Cap. | 2.11% | 2.19% | 22.32x | -87.49x | 7.44x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition